CarePay Transforms India's Elective Healthcare with AI-Driven Instant EMI Financing

In India, 60% of patients delay essential elective procedures like IVF, LASIK, and dental treatments due to high upfront costs.

CarePay, an innovative Indian fintech firm, is revolutionizing this space by embedding an AI-powered platform directly into clinics for instant, zero-cost financing.

CarePay's Groundbreaking Platform

The platform enables patients to pay for treatments in easy monthly installments without any interest or processing fees.

Founded by entrepreneurs who identified the financing gap during their previous healthcare venture, CarePay launched to bridge the $60 billion elective healthcare market in India.

Clinics integrated with CarePay report a 20-25% increase in procedure volumes as financing removes financial barriers for patients.

The AI-driven system provides approvals in seconds using alternative data, making it accessible even to those without traditional credit scores.

Over the years, CarePay has raised $61.8 million across multiple rounds, with the latest funding fueling expansion.

Impact and Future Growth

This model not only boosts clinic revenues but also enhances patient satisfaction and health outcomes in underserved segments.

Looking ahead, CarePay plans to partner with more hospitals and launch advanced features like its Careena EMI platform nationwide.

As India's healthcare sector grows, fintech innovations like CarePay are set to unlock unprecedented access to elective care.

By addressing out-of-pocket payment challenges, CarePay is paving the way for a more inclusive healthcare ecosystem.